| human | Q5 |
| P6178 | Dimensions author ID | 0742512342.44 |
| P496 | ORCID iD | 0000-0002-5625-0792 |
| P3829 | Publons author ID | 2377940 |
| P1053 | ResearcherID | J-4766-2015 |
| P1153 | Scopus author ID | 8983326100 |
| P734 | family name | Naesens | Q122422011 |
| Naesens | Q122422011 | ||
| Naesens | Q122422011 | ||
| P735 | given name | Maarten | Q1882274 |
| Maarten | Q1882274 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q91664663 | A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection |
| Q35379384 | A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation |
| Q42848519 | A peripheral blood diagnostic test for acute rejection in renal transplantation. |
| Q42789747 | A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients |
| Q90147342 | Age-related changes in DNA methylation affect renal histology and post-transplant fibrosis |
| Q48170563 | Anastomosis time as risk factor for kidney transplant outcome: more pieces to the puzzle |
| Q98937850 | Autoantibodies against Granulocyte Macrophage Colony-Stimulating Factor and Nocardia infection in solid organ transplant recipients |
| Q38546316 | Autophagy and the Kidney: Implications for Ischemia-Reperfusion Injury and Therapy |
| Q43254664 | Balancing efficacy and toxicity of kidney transplant immunosuppression |
| Q28253940 | Bartter's and Gitelman's syndromes: from gene to clinic |
| Q80316046 | CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients |
| Q87676573 | Calcineurin Inhibitor Nephrotoxicity in the Era of Antibody-Mediated Rejection |
| Q34945314 | Calcineurin inhibitor nephrotoxicity |
| Q37123164 | Calcium metabolism in the early posttransplantation period. |
| Q44276263 | Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure. |
| Q85811327 | Combined effects of CYP3A5*1, POR*28, and CYP3A4*22 single nucleotide polymorphisms on early concentration-controlled tacrolimus exposure in de-novo renal recipients |
| Q44776130 | Combined kidney and intestinal transplantation in patients with enteric hyperoxaluria secondary to short bowel syndrome. |
| Q86221068 | Completeness and satisfaction with the education and information received by patients immediately after kidney transplant: a mixed-models study |
| Q46579648 | Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients. |
| Q115016206 | Data-Driven Chronic Allograft Phenotypes: A Novel and Validated Complement for Histologic Assessment of Kidney Transplant Biopsies |
| Q39630789 | Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism |
| Q92844878 | Delayed Bleeding of the Transplant Duodenum After Simultaneous Kidney-pancreas Transplantation: Case Series |
| Q33561691 | Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts |
| Q46589242 | Drug interaction between mycophenolate mofetil and rifampin: possible induction of uridine diphosphate-glucuronosyltransferase |
| Q46428863 | Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients |
| Q98235850 | Eplet Mismatch Load and De Novo Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort Study |
| Q38914846 | Establishing Biomarkers in Transplant Medicine: A Critical Review of Current Approaches. |
| Q43472438 | Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity |
| Q24654702 | Expression of complement components differs between kidney allografts from living and deceased donors |
| Q53781355 | Foretelling Graft Outcome by Molecular Evaluation of Renal Allograft Biopsies: The GoCAR Study. |
| Q37560649 | Genome-Wide Association Study of Acute Renal Graft Rejection |
| Q90734361 | Histological picture of ABMR without HLA-DSA: Temporal dynamics of effector mechanisms are relevant in disease reclassification |
| Q90941271 | Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome |
| Q113756467 | Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury |
| Q101386997 | Incidence, Characteristics, and Outcome of COVID-19 in Adults on Kidney Replacement Therapy: A Regionwide Registry Study |
| Q91592778 | Indications, risks and impact of failed allograft nephrectomy |
| Q49788145 | Inflammatory macrophage-associated 3-gene signature predicts subclinical allograft injury and graft survival. |
| Q51902005 | Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples. |
| Q40689820 | Intragraft Antiviral-Specific Gene Expression as a Distinctive Transcriptional Signature for Studies in Polyomavirus-Associated Nephropathy. |
| Q86654191 | Intrarenal resistive index after renal transplantation |
| Q87278948 | Intrarenal resistive index after renal transplantation |
| Q41483647 | Invasive aspergillosis after kidney transplant: case-control study. |
| Q58428552 | Ischemia-Induced DNA Hypermethylation during Kidney Transplant Predicts Chronic Allograft Injury |
| Q44432001 | Localization, etiology and impact of calcium phosphate deposits in renal allografts. |
| Q44684730 | Looking back to evaluate the causes of graft loss? A response to Dr. Halloran and Dr. Sellares |
| Q51574603 | Looking into the crystal chip: can microarrays predict graft function? |
| Q38835649 | Lymphocyte-depleting induction and steroid minimization after kidney transplantation: A review. |
| Q43450011 | Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients |
| Q41586193 | Microscopic nephrocalcinosis in chronic kidney disease patients. |
| Q47702694 | Mineral metabolism disturbances in kidney donors: smoke, no fire (yet). |
| Q102388294 | Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection |
| Q37782254 | Molecular diagnostics in transplantation. |
| Q43067039 | Monitoring calcineurin inhibitor therapy: localizing the moving target |
| Q79294815 | Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients |
| Q83388944 | Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury |
| Q91594231 | Occurrence of Diabetic Nephropathy After Renal Transplantation Despite Intensive Glycemic Control: An Observational Cohort Study |
| Q95433271 | Organ transplantation after cardiac death |
| Q39973995 | Phosphorus metabolism in peritoneal dialysis- and haemodialysis-treated patients. |
| Q54702468 | Post-streptococcal glomerulonephritis: not an extinct disease! |
| Q53522735 | Postimplantation X-ray parameters predict functional catheter problems in peritoneal dialysis. |
| Q38151922 | Pretransplant identification of acute rejection risk following kidney transplantation |
| Q34483895 | Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study |
| Q40036192 | RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection |
| Q26767324 | Rabbit antithymocyte globulin and donor-specific antibodies in kidney transplantation--A review |
| Q33408239 | Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome |
| Q36947345 | Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation |
| Q37246931 | Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD. |
| Q41507839 | Resolution of diffuse skin and systemic Kaposi's sarcoma in a renal transplant recipient after introduction of everolimus: a case report |
| Q52960515 | Rethinking peritubular capillary basement membrane multilayering in renal transplant pathology: a case report. |
| Q54571062 | Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients. |
| Q125903679 | SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys |
| Q88015493 | Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease |
| Q91814128 | Specificity, strength, and evolution of pretransplant donor-specific HLA antibodies determine outcome after kidney transplantation |
| Q46834233 | Stability of mycophenolic acid and glucuronide metabolites in human plasma and the impact of deproteinization methodology. |
| Q83766881 | Standardizing resistive indices in healthy pediatric transplant recipients of adult-sized kidneys |
| Q54309825 | Stanniocalcin supports the functional adaptation of adult-sized kidneys transplanted into the pediatric recipients. |
| Q36281955 | Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation |
| Q80470291 | Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year |
| Q84833988 | Switching from calcineurin inhibitors to Mammalian target of rapamycin inhibitors--finally caught the right wave? |
| Q43043698 | Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients |
| Q80563022 | Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation |
| Q36260230 | Telomere length, cardiovascular risk and arteriosclerosis in human kidneys: an observational cohort study |
| Q79947877 | Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients |
| Q89074614 | The 1-year Renal Biopsy Index: a scoring system to drive biopsy indication at 1-year post-kidney transplantation |
| Q40111285 | The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients. |
| Q38701049 | The Emerging Role of DNA Methylation in Kidney Transplantation: A Perspective |
| Q98302423 | The Histological Picture of Indication Biopsies in the First 2 Weeks after Kidney Transplantation |
| Q48371293 | The Impact of Anastomosis Time During Kidney Transplantation on Graft Loss: A Eurotransplant Cohort Study. |
| Q84575138 | The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients |
| Q96432047 | The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study |
| Q83429549 | The bumpy road of genomic medicine in transplantation: lessons from studies on calcineurin inhibitor nephrotoxicity |
| Q36719246 | The clinical impact of humoral immunity in pediatric renal transplantation. |
| Q89123249 | The clinical significance of epitope mismatch load in kidney transplantation: A multicentre study |
| Q51528486 | The dual role of epithelial-to-mesenchymal transition in chronic allograft injury in pediatric renal transplantation. |
| Q98952786 | The effect of IGL-1 preservation solution on outcome after kidney transplantation: A retrospective single-center analysis |
| Q40410816 | The effect of anastomosis time on outcome in recipients of kidneys donated after brain death: a cohort study |
| Q51740341 | The evolution of nonimmune histological injury and its clinical relevance in adult-sized kidney grafts in pediatric recipients. |
| Q34439824 | The histology of kidney transplant failure: a long-term follow-up study. |
| Q80798786 | The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide |
| Q46731220 | The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients |
| Q46582267 | The influence of renal transplantation on retained microbial-human co-metabolites |
| Q41828910 | The predictive value of kidney allograft baseline biopsies for long-term graft survival |
| Q87055318 | The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis |
| Q48162490 | The time dependency of renal allograft histology |
| Q88139167 | Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation |
| Q97530146 | Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies |
| Q93079955 | Transcriptional trajectories of human kidney injury progression |
| Q89083482 | Transplantation: BENEFIT of belatacept: kidney transplantation moves forward |
| Q47799865 | Tubulointerstitial expression and urinary excretion of connective tissue growth factor 3 months after renal transplantation predict interstitial fibrosis and tubular atrophy at 5 years in a retrospective cohort analysis. |
| Q57066176 | Unraveling the Cause of Anuria Post Kidney Transplantation by Renal Scintigraphy |
| Q50876181 | Urinary connective tissue growth factor is associated with human renal allograft fibrogenesis. |
| Q38645390 | Zero-Time Renal Transplant Biopsies: A Comprehensive Review. |
| Q48010509 | suPAR and FSGS: the gap between bench and bedside. |
Search more.